FindTrial
Sign In

How common is less muscle mass in patient with end stage liver disease

To study prevalence of Sarcopenia in a patients with decompensated liver cirrhosis in tertiary care hospital - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073770
Enrollment
97
Registered
2024-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K740- Hepatic fibrosis

Interventions

Intervention1: Nil: Nil

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients visiting (OPD/IPD) in AVBRH having a diagnosis of cirrhosis of liver will be included in this study. The diagnosis of Sarcopenia in liver cirrhosis is by various definitions of sarcopenia .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To study prevalence of sarcopenia in a patients with cirrhosis of liverTimepoint: At baseline—

Secondary

MeasureTime frame
NilTimepoint: N/A—

Countries

India

Contacts

Public ContactDr Virendra Bhad

Datta Meghe Institute Of Higher Education and Research

drvijendrakirnake@gmail.com07768901370

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026